Beating Leukemia with Groundbreaking CAR-T Cell Therapy
Dr. Stephan A. Grupp made history when he treated the first child with CAR T cell therapy, Emily Whitehead, who is now more than five years cancer-free. In CAR-T cell therapy, a patient's own genetically altered immune cells fight cancer. We learnt about the CAR-T cell research journey and FDA approval in our discussion with Dr. Carl June of University of Pennsylvania in the first episode of our CAR-T talk series. In this episode, we are talking to Dr. Stephan A. Grupp who carried out the early pediatric trials and the global Novartis trial at CHOP leading to the FDA approval. The discussion would focus on required preparations, recovery phase and where this treatment can be availed. We will also be joined by Tom Whitehead, father of Emily Whitehead who will share his experience with the trial and progress of Emily post CAR-T cell therapy.
CureTalks is an online Talk featuring a leading expert in conversation with a panel and the audience. The audience can ask questions from the panelists LIVE on the talk by dial-ing in. To hear the talk via phone or on-line, please add your email on the left; we will send you Live Talk access details. You can also write your questions in the Comments/Questions section below and your question maybe selected to be featured on the talk.